As of 10:36am ET
| -0.10 / -1.79%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.50, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +109.09% increase from the last price of 5.50.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.